Chk2 and REGγ-dependent DBC1 regulation in DNA damage induced apoptosis

被引:38
作者
Magni, Martina [1 ]
Ruscica, Vincenzo [1 ]
Buscemi, Giacomo [2 ]
Kim, Ja-Eun [3 ]
Nachimuthu, Benjamin Tamilselvan [4 ]
Fontanella, Enrico [1 ]
Delia, Domenico [1 ]
Zannini, Laura [1 ]
机构
[1] Fdn IRCCS Ist Nazl Tumori, Dept Expt Oncol, I-20133 Milan, Italy
[2] Univ Milan, Dept Biosci, I-20133 Milan, Italy
[3] Kyung Hee Univ, Sch Med, Dept Pharmacol, Seoul 130701, South Korea
[4] CNR, IGM, I-27100 Pavia, Italy
关键词
PROTEASOME ACTIVATOR; SER-473; PHOSPHORYLATION; CELLULAR-RESPONSE; PROTEIN-KINASE; CANCER-CELLS; SIRT1; INTERACTS; ACETYLATION; DEACETYLASE; INHIBITION;
D O I
10.1093/nar/gku1065
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Human DBC1 (Deleted in Breast Cancer 1; KIAA1967; CCAR2) is a protein implicated in the regulation of apoptosis, transcription and histone modifications. Upon DNA damage, DBC1 is phosphorylated by ATM/ATR on Thr454 and this modification increases its inhibitory interaction with SIRT1, leading to p53 acetylation and p53-dependent apoptosis. Here, we report that the inhibition of SIRT1 by DBC1 in the DNA damage response (DDR) also depends on Chk2, the transducer kinase that is activated by ATM upon DNA lesions and contributes to the spreading of DNA damage signal. Indeed we found that inactivation of Chk2 reduces DBC1-SIRT1 binding, thus preventing p53 acetylation and DBC1-induced apoptosis. These events are mediated by Chk2 phosphorylation of the 11S proteasome activator REG gamma on Ser247, which increases REG gamma-DBC1 interaction and SIRT1 inhibition. Overall our results clarify the mechanisms underlying the DBC1-dependent SIRT1 inhibition and link, for the first time, Chk2 and REG gamma to the ATM-DBC1-SIRT1 axis.
引用
收藏
页码:13150 / 13160
页数:11
相关论文
共 45 条
  • [41] A role for the deubiquitinating enzyme USP28 in control of the DNA-damage response
    Zhang, Dong
    Zaugg, Kathrin
    Mak, Tak W.
    Elledge, Stephen J.
    [J]. CELL, 2006, 126 (03) : 529 - 542
  • [42] SILAC-based phosphoproteomics reveals an inhibitory role of KSR1 in p53 transcriptional activity via modulation of DBC1
    Zhang, H.
    Xu, Y.
    Filipovic, A.
    Lit, L. C.
    Koo, C-Y
    Stebbing, J.
    Giamas, G.
    [J]. BRITISH JOURNAL OF CANCER, 2013, 109 (10) : 2675 - 2684
  • [43] DBC1 is over-expressed and associated with poor prognosis in colorectal cancer
    Zhang, Yongguo
    Gu, Yong
    Sha, Sumei
    Kong, Xiangyun
    Zhu, Hongwu
    Xu, Bin
    Li, Yijun
    Wu, Kaichun
    [J]. INTERNATIONAL JOURNAL OF CLINICAL ONCOLOGY, 2014, 19 (01) : 106 - 112
  • [44] Negative regulation of the deacetylase SIRT1 by DBC1
    Zhao, Wenhui
    Kruse, Jan-Philipp
    Tang, Yi
    Jung, Sung Yun
    Qin, Jun
    Gu, Wei
    [J]. NATURE, 2008, 451 (7178) : 587 - U11
  • [45] hMOF Acetylation of DBC1/CCAR2 Prevents Binding and Inhibition of SirT1
    Zheng, Hong
    Yang, Leixiang
    Peng, Lirong
    Izumi, Victoria
    Koomen, John
    Seto, Edward
    Chen, Jiandong
    [J]. MOLECULAR AND CELLULAR BIOLOGY, 2013, 33 (24) : 4960 - 4970